Back

Panel discussion - PCSK9 inhibitors: the evidence-based story.

29 August 2017 (13:30 - 13:40)
Organised by:
Congress Presentation Part of: PCSK9 inhibitors: the evidence-based story Atherosclerosis Open Access ESC Congress 2017

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Introduction - PCSK9 inhibitors: the evidence-based story.
Professor K. Ray (London, GB)
Video
Presentation thumbnail
The LDL-C paradigm.
Professor B. Ference (Cambridge, GB)
Video
Presentation thumbnail
Atherosclerosis regression and low LDL-C.
Professor S. Nicholls (Melbourne, AU)
Slides Video
Presentation thumbnail
Evidence for CV event reduction with lower LDL-C.
Professor C. Packard (Glasgow, GB)
Video
Presentation thumbnail
What questions remain unanswered?
Professor K. Ray (London, GB)
Video

Access the full session

Session thumbnail
PCSK9 inhibitors: the evidence-based story

The Event

Event poster

ESC Congress 2017

29 August 2017 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Evaluating risk-based allocation strategies for PCSK9 inhibitors: results from a simulation study in a contemporary ASCVD cohort
26 August 2023
thumbnail
Webinar
New trial evidence in the field of lipid management
19 April 2024
thumbnail
Congress Presentation
Breaking through: CETP inhibitors and the future of lipid therapy
29 August 2025
thumbnail
Congress Presentation
Novel insights into the management of German patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: baseline characteristics from the PERI-DYS study
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources